Wolfgang Arns - Concepedia

Author

Wolfgang Arns

Also Known As

Frank Lehner, Martina Porstner, W ARNS, W Arns, W. Arns, W.A. Arns, Wolfgang Arns, Wolfgang Arns for the APOLLO Study Group

144

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin University Hospital Cologne Heidelberg University Medizinische Hochschule Hannover Novartis (Germany)

About

Wolfgang Arns is an author at Charité - Universitätsmedizin Berlin specializing in kidney transplant, nephrology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	17	1K
2	Nephrology	12	15	1K
3	Public Health	1	1	14
4	Health Policy	1	1	14
5	Immunology	1	1	78

Wolfgang Arns

Publications

Citations

H-Index

Page 1

	Year	Citations
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease Gerd Walz, Klemens Budde, Marwan Mannaa, New England Journal of Medicine	2010	571
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial Klemens Budde, Thomas Becker, Wolfgang Arns, The Lancet UrologyTransplantationKidney TransplantKidney ResearchDe-novo Kidney Transplants	2011	353
Enteric Coated Mycophenolate Sodium is Therapeutically Equivalent to Mycophenolate Mofetil in de novoRenal Transplant Patients Maurizio Salvadori, Herwig Holzer, Angelo de Mattos, American Journal of Transplantation Mycophenolate MofetilTransplantationXenotransplantationKidney TransplantMycophenolic Acid	2004	317
Patient-Reported Gastrointestinal Symptom Burden and Health-Related Quality of Life following Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Laurence Chan, Shamkant Mulgaonkar, Rowan G. Walker, Transplantation	2006	158
Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study Susanne Stoelben, Wolfgang Arns, Lutz Renders, Transplant International	2013	135
Enteric‐coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil Wolfgang Arns, Stephan Breuer, Somesh Choudhury, Clinical Transplantation	2005	132
Five-Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study Klemens Budde, Frank Lehner, Claudia Sommerer, American Journal of Transplantation	2014	126
Conversion From Cyclosporine to Everolimus at 4.5 Months Posttransplant: 3-Year Results From the Randomized ZEUS Study Klemens Budde, Frank Lehner, Claudia Sommerer, American Journal of Transplantation	2012	84
Sotrastaurin, a Novel Small Molecule Inhibiting Protein-Kinase C: Randomized Phase II Study in Renal Transplant Recipients S. Friman, Wolfgang Arns, Björn Nashan, American Journal of Transplantation UrologyTransplantationNovel TherapyKidney TransplantMedicine	2011	78
Within-Day Consistency in Cyclosporine Pharmacokinetics from a Microemulsion Formulation in Renal Transplant Patients John M. Kovarik, Edgar A. Mueller, Johannes B. van Bree, Therapeutic Drug Monitoring Daytime FastingRenal Transplant PatientsPharmaceutical ScienceWithin-day ConsistencyImmunosuppressive Therapy	1994	77

Page 1